Skip to content
Wednesday, November 11, 2026
Trusted House Now

Zimbabwe Declines ‘One-Sided’ American Healthcare Assistance Agreement Because of Information Concerns

Health funding illustration
The offered US funding was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has declined a significant American health deal worth 367 million US dollars (272 million pounds) spanning five years over the United States' insistence on sensitive biological samples.

This rejection became public following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "lopsided".

An official representative later explained that the US was seeking genetic material for research and commercial gain while was not willing to guarantee the resulting advantages from any future medical innovations.

"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has appealed for continued dialogue to find a agreement acceptable to all parties so the nation's critical HIV programme can be sustained.

Wider Context

This rejection follows a comparable situation in neighbouring Kenya, where a high court blocked a related deal with the US after legal challenges were filed about the safety of citizens' medical information.

After resuming office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

USAID had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his government was seeking government-to-government deals to boost openness and accountability.

According to statements, Sixteen African countries have so far agreed to similar health pacts, representing more than $18.3bn in new funding.

Details of the Rejected Deal

The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this cooperation could have provided significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," he stated.

"Put simply, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our population should a future disease outbreak arise."

Sovereignty and Global Health

He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks previously set up through the international organization.

The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.

"This framework is intended to guarantee that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to create them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," he added.

"We encourage continued discussions with our American counterparts on how future collaboration might be designed in a manner that respects the independence and interests of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that talks must proceed given that a large portion of the country's Aids initiatives were funded by international support.

"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group commented.

This impasse emphasises the continuing debate between accepting crucial international aid and protecting a country's data in an increasingly data-driven world.

TT
The writer

Tonya Taylor

A real estate enthusiast with over a decade of experience in property markets and home staging.

Trusted House Now

Type to search articles.